Table 2 Prevalence and determinants of transmitted Drug Resistance (TDR) stratified by HIV-1 subtypes

Sex

Female

90(17.9%)

6(6.7%)

0.077

0.782

141(15.2%)

4(2.8%)

4.80E-30

1

43(32.8%)

11(25.6%)

0.020

0.887

47(21.5%)

1(2.1%)

1.63E-28

1

Male

414(82.1%)

34(8.2%)

787(84.8%)

21(2.7%)

88(67.2%)

20(22.7%)

172(78.5%)

4(2.3%)

Age

< 30

134(26.6%)

6(4.5%)

5.844

0.054

178(19.2%)

4(2.2%)

0.301

0.860

17(13.0%)

5(29.4%)

0.371

0.831

37(16.9%)

1(2.7%

2.975

0.226

30–49

200(39.7%)

14(7.0%)

364(39.2%)

11(3.0%)

34(26.0%)

8(23.5%)

62(28.3%)

3(4.8%)

≥ 50

170(33.7%)

20(11.8%)

386(41.6%)

10(2.6%)

80(61.1%)

18(22.5%)

120(54.8%)

1(0.8%)

Marital status

Single

204(40.5%)

8(3.9%)

12.692

0.005

309(33.3%)

8(2.6%

7.335

0.062

27(20.6%)

9(33.3%)

2.379

0.498

66(30.1%)

3(4.5%)

2.703

0.44

Married

180(35.7%)

14(7.8%)

388(41.8%)

10(2.6%)

64(48.9%)

15(23.4%)

105(48.0%)

2(1.9%)

Divorced/widowed

116(23.0%)

17(14.7%)

217(23.4%)

5(2.3%)

36(27.5%)

6(16.7%)

44(20.1%)

0

Uknown

5(1.0%)

1(20.0%)

14(1.5%)

2(14.3%)

4(3.1%)

1(25.0%)

4(1.8%)

0

Education

Primary

142(28.2%)

17(12.0%)

8.574

0.073

349(37.6%)

11(3.2%)

3.42

0.490

77(58.8%)

18(23.4%)

2.612

0.455

89(40.6%)

0

7.035

0.071

Junior

186(36.9%)

17(9.1%)

320(34.5%)

11(3.4%)

40(30.5%)

8(20.0%)

84(38.4%)

2(2.4%)

Senior

86(17.1%)

3(3.5%)

132(14.2%)

2(1.5%)

8(6.1%)

2(25.0%)

24(11.0%)

1(4.2%)

College

90(17.9%)

3(3.3%)

125(13.5%)

1(0.8%)

6(4.6%)

3(50.0%)

22(10.0%)

2(9.1%)

Unknown

1(0.2%)

0

2(0.2%)

0

0

0

0

0

Ethnicity

Ethnic minorities

32(6.3%)

1(3.1%)

0.494

0.482

44(4.7%)

1(2.3%)

1.68E-27

1

10(7.6%)

3(30.0%)

0.011

0.918

9(4.1%)

0

0.245

0.885

Han

472(93.7%)

39(8.3%)

884(95.3%)

24(2.7%)

121(92.4%)

28(23.1%)

209(95.4%)

5(2.4%)

Unknown

0

0

0

0

1

0

Transmission route

Heterosexual

300(59.5%)

20(6.7%)

12.826

0.005

565(60.9%)

15(2.7%)

5.095

0.165

113(86.3%)

28(24.8%)

0.608

0.738

136(62.1%)

2(1.5%)

2.838

0.417

Homosexual

192(38.1%)

18(9.4%)

343(37.0%)

8(2.3%)

13(9.9%)

2(15.4%)

70(32.0%)

2(2.9%)

Other

1(0.2%)

1(100.0%)

2(0.2%)

0

5(3.8%)

1(20.0%)

2(0.9%)

0

Unknown

11(2.2%)

1(9.1%)

18(1.9%)

2(11.1%)

0

0

11(5.0%)

1(9.1%)

CD4 + T cell count(cells/mm3)

< 200

225(44.6%)

18(8.0%)

2.539

0.281

336(36.2%)

12(3.6%)

3.355

0.187

37(28.2%)

8(21.6%)

1.932

0.381

90(41.1%)

1(1.1%)

4.559

0.102

200–499

226(44.8%)

15(6.6%)

498(53.7%)

9(1.8%)

78(59.5%)

17(21.8%)

105(47.9%)

2(1.9%

≥ 500

53(10.5%)

7(13.2%)

94(10.1%)

4(4.3%)

16(12.2%)

6(37.5%)

24(11.0%)

2(8.3%)

Year

2020

147(29.2%)

9(6.1%)

7.234

0.065

252(27.2%)

3(1.2%)

11.04

0.012

58(44.3%)

18(31.0%)

7.928

0.048

64(29.2%)

1(1.6%)

2.215

0.529

2021

153(30.4%)

7(4.6%)

260(28.0%)

5(1.9%)

33(25.2%)

9(27.3%)

66(30.1%)

1(1.5%)

2022

116(23.0%)

13(11.2%)

238(25.6%)

6(2.5%)

18(13.7%)

0

54(24.7%)

1(1.9%)

2023

88(17.5%)

11(12.5%)

178(19.2%)

11(6.2%)

22(16.8%)

4(18.2%)

35(16.0%)

2(5.7%)